Nektar Therapeutics (LTS:0UNL) Receivables Turnover : 20.17 (As of Sep. 2024)

Nektar Therapeutics Receivables Turnover Chart

Nektar Therapeutics Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Receivables Turnover		Get a 7-Day Free Trial					2.86	4.04	3.32	6.47	25.08

Nektar Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Receivables Turnover	Get a 7-Day Free Trial															13.64	14.01	8.98	9.76	20.17

Competitive Comparison of Nektar Therapeutics's Receivables Turnover

For the Biotechnology subindustry, Nektar Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nektar Therapeutics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nektar Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Nektar Therapeutics's Receivables Turnover falls into.

Nektar Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Nektar Therapeutics's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Nektar Therapeutics's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nektar Therapeutics  (LTS:0UNL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Nektar Therapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Nektar Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Nektar Therapeutics Business Description